Actualités



Retour


09/03/2017
Dynacure appoints its Management Team and members of the Board of Directors
Dynacure’s leadership team includes Stephane van Rooijen (CEO), Frédéric Legros (COO) and Leen Thielemans (Head of Development). The team will focus on the company’s preclinical and clinical development programs in CNM and the expansion of its pipeline in rare disease treatments. [...]

Télécharger le fichier pdf





X

X